Detalhe da pesquisa
1.
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Nat Immunol
; 16(2): 170-177, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25501631
2.
Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study.
BMC Infect Dis
; 23(1): 301, 2023 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37158835
3.
Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
J Virol
; 95(19): e0061921, 2021 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232731
4.
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Nat Immunol
; 16(7): 785, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086146
5.
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Nat Immunol
; 16(5): 544, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25898199
6.
Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.
J Clin Microbiol
; 57(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429254
7.
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.
J Virol
; 92(23)2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185598
8.
Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
J Virol
; 92(7)2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321308
9.
Use of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections.
Emerg Infect Dis
; 24(7): 1355-1359, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29912689
10.
Potential Point-of-Care Testing for Dengue Virus in the Field.
J Clin Microbiol
; 56(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514934
11.
Correction to: Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study.
BMC Infect Dis
; 23(1): 401, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312023
12.
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
Clin Infect Dis
; 65(11): 1829-1836, 2017 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020159
13.
Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
J Virol
; 89(14): 7348-62, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972550
14.
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
PLoS Pathog
; 10(10): e1004386, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25275316
15.
Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry.
J Biol Chem
; 289(48): 33149-60, 2014 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25326389
16.
High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.
J Virol
; 87(23): 12562-75, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24027331
17.
Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria.
Int J Infect Dis
; 139: 92-100, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056689
18.
Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
Emerg Microbes Infect
; 13(1): 2301666, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38163752
19.
Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines.
Front Immunol
; 14: 1202055, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554332
20.
Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals.
Microbiol Spectr
; 11(4): e0408122, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428104